Haikal Abdullah, El-Neketi Mona, Helal Manar G, Abou-Zeid Laila A, Hassan Madiha A, Gohar Ahmed A
Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
J Ethnopharmacol. 2025 Jan 13;339:119133. doi: 10.1016/j.jep.2024.119133. Epub 2024 Nov 19.
Mentha longifolia L. has been employed to treat cough, lung inflammation, and bronchial asthma disorders.
Our study was carried out to investigate the medicinal effect of the flavonoids derived from M. longifolia, specifically didymin, linarin, rutin, and TMF, as well as the whole extracts of M. longifolia subsp. typhoides and M. longifolia subsp. schimperi, in comparison to dexa, in a mice model of ovalbumin-allergic asthma (OVA).
After inhaling OVA, the mice developed acute asthma symptoms. Mice were subjected orally to Dexa and/or isolated flavonoids. The study assessed total and differential leukocyte counts, LDH concentration, and total protein concentration in BALF, reduced levels of GSH and total NOx products in lung tissues and analyzed the lung specimens by staining them with hematoxylin and eosin (H & E).
Histopathological analysis of the right lung lobes demonstrated that the isolated flavonoids exhibited a significant anti-inflammatory effect higher than Dexa as shown by decreasing the overall and distinct leukocyte counts, LDH levels, and total protein levels in BALF, as compared to the OVA group (p < 0.05). TMF was the most effective and the other tested flavonoids are more effective than Dexa but less than TMF. In addition, all tested flavonoids and Dexa significantly (p < 0.05) mitigated OVA-induced oxidative stress as evidenced by diminished lung NOx level and elevated GSH level. Computational docking studies proved recognition of didymin, linarin, rutin, and TMF to the human leukocyte elastase binding sites.
The tested flavonoids; didymin, linarin, rutin, and TMF successfully inhibit Ova-induced allergic asthma in mice through their anti-inflammatory and antioxidant activities and may represent promising candidate as a remedy for allergic asthma.
长叶薄荷已被用于治疗咳嗽、肺部炎症和支气管哮喘疾病。
我们开展本研究以调查源自长叶薄荷的黄酮类化合物(具体为地迪明、蒙花苷、芦丁和TMF)以及长叶薄荷亚种伤寒长叶薄荷和长叶薄荷亚种辛氏长叶薄荷的全提取物,与地塞米松相比,在卵清蛋白过敏性哮喘(OVA)小鼠模型中的药用效果。
吸入OVA后,小鼠出现急性哮喘症状。小鼠口服地塞米松和/或分离出的黄酮类化合物。该研究评估了BALF中的白细胞总数和分类计数、LDH浓度以及总蛋白浓度,肺组织中GSH水平降低和总NOx产物水平,并通过苏木精和伊红(H&E)染色分析肺标本。
右肺叶的组织病理学分析表明,与OVA组相比,分离出的黄酮类化合物表现出比地塞米松更强的显著抗炎作用,表现为BALF中的白细胞总数和分类计数、LDH水平以及总蛋白水平降低(p < 0.05)。TMF最有效,其他测试的黄酮类化合物比地塞米松更有效,但比TMF效果差。此外,所有测试的黄酮类化合物和地塞米松均显著(p < 0.05)减轻了OVA诱导的氧化应激,表现为肺NOx水平降低和GSH水平升高。计算机对接研究证明地迪明、蒙花苷、芦丁和TMF可识别人类白细胞弹性蛋白酶结合位点。
测试的黄酮类化合物;地迪明、蒙花苷、芦丁和TMF通过其抗炎和抗氧化活性成功抑制了小鼠OVA诱导的过敏性哮喘,可能是过敏性哮喘治疗的有前途的候选药物。